The effects of chiglitazar and metformin on insulin resistance in women with a normal BMI and polycystic ovary syndrome: a randomized controlled study.

BMC Endocr Disord · 2025 · PMC12746622 · PMID 41331576

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP >0.05actually significant

Although Chiglitazar demonstrated numerically more pronounced reductions in LH and FSH levels within the IR0 ≥ 12 subgroup, while metformin showed a potentially greater effect in the IR0 < 12 subgroup, these intergroup differences did not reach statistical significance ( P >0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.